Industry focus / Healthcare and Life Sciences
Aevis supports the technology around clinical, research and business operations in healthcare and life sciences — where availability is measured in the consequence of its absence, sensitive information carries obligations that do not expire, and change has to be evidenced rather than announced.
Availability where it is clinical. Evidence where it is regulated. Support wherever the work happens.
Design for recovery where downtime has a consequence.
Protect sensitive information at every hand-off.
Make change defensible after the fact, not only approved before it.
One service view · one decision trail
Sector pressure
Clinical delivery, regulated research and ordinary business operations sit on the same estate and are governed as though they were the same thing. They are not, and the design brief has to say which is which before anything is standardised.
A system that is unavailable during a shift is not an inconvenience to be reported in the monthly pack. Care continues on paper, and the reconciliation afterwards is its own workload.
Is there a rehearsed downtime procedure, or only a recovery target?
Patient, participant and research data moves between clinical systems, imaging, laboratory platforms, research environments and external partners, each hand-off a place where access can widen quietly.
Can you state who can reach this data today, without asking anyone?
In regulated research and manufacturing, an unqualified change is not a rollback — it is a deviation with a record attached. Ordinary IT change practice does not survive contact with that requirement.
Does the change process know which environments are validated?
Wards, theatres, laboratories, community teams and field research all need shared devices, fast authentication and support that reaches them where they work rather than where the service desk is.
How long does a clinician spend logging in, ten times a shift?
Operating agenda
These capabilities are designed as one operating system. Each can begin as a focused engagement, but the value compounds when service, security, workplace, data and delivery share the same governance spine.
Operate infrastructure, cloud and applications around clinical and research services and their consequence, rather than around isolated technology towers.
Operate the devices, shared endpoints, authentication and support model the front line actually uses, including the ones that never leave a ward or a bench.
Bring continuous monitoring, investigation, vulnerability work and response readiness into the same cadence as the services holding patient and participant information.
Turn requests, incidents, problems, changes and control tasks into connected workflows with accountability that holds across clinical, research and corporate boundaries.
Strengthen the movement, ownership and operational visibility of data across clinical systems, research platforms, reporting and external collaborations.
Modernise priority applications and interfaces in controlled increments, preserving the behaviours, records and validation status the organisation cannot afford to lose.
Control by design
A control environment assembled after the work is a reconstruction, and reconstructions are where gaps are found. The stronger arrangement is one where the record of a change is created by making the change.
Risk posture, service health, investment decisions and accepted exceptions.
Ownership, dependencies, levels, changes, incidents and recurring risks.
Requests, engineering work, approvals, testing, qualification and release evidence.
Events, logs, performance, security signals, capacity and configuration state.
Responsibility boundaryClinical safety, care decisions, research conduct, regulatory interpretation and formal control approvals remain the client’s and its accountable officers’. Aevis provides technology operations, engineering and governance support within the agreed responsibility model, and makes no clinical, diagnostic or medical-device claim.
Healthcare contexts
What is being protected determines the control boundary. We shape the engagement around the service model, the users, the technology estate and the third parties already in place.
Operate the clinical and administrative estate around ward, theatre, outpatient and community services, with support that reaches the point of care.
Availability · access speed · downtime procedureSupport research, laboratory and manufacturing-adjacent environments where change control and qualification status govern what may be touched and when.
Validated change · records · segregationImprove the resilience and service management around instruments, imaging platforms, integration interfaces and the storage behind them.
Interface reliability · capacity · instrument supportOperate and modernise patient-facing platforms, portals and the integration layer between them and the systems of record they depend on.
Journey continuity · integration · data protectionEngagement path
The first job is to understand what must remain true for patients, clinicians, researchers and control owners. Technology choices follow that operating brief.
Define the business service, critical journeys, stakeholders and non-negotiable constraints.
Service briefTrace technology, data, suppliers, controls, validation status and operating dependencies.
Dependency mapSeparate urgent exposure, structural weakness and modernisation opportunity into an agreed sequence.
Roadmap and measuresEstablish ownership, governance, transition controls and the delivery or operations cadence.
Mobilisation planRun the service, review evidence and feed operational learning into the next improvement cycle.
Governed service cycleDesigned outcomes
Baselines and targets are agreed for each engagement. We do not import generic percentages into a clinical environment and call them a business case.
Coverage of critical services, dependencies and accountable owners.
Detection, escalation, restoration and downtime-procedure performance.
Time to reach a clinical system, and support responsiveness at the point of care.
Completeness and timeliness of decision, approval and closure records.
Measures are defined with the client and depend on scope, baseline quality, data availability and the responsibilities assigned to Aevis.
Relevant services
Industry context changes how the work is governed and measured. The underlying capabilities can be contracted together or as a focused intervention.
Frequently asked questions
The useful answers depend on the operating boundary. These are the principles we use before a detailed assessment establishes the exact scope.
We operate the technology those systems depend on and the integration around them, within the scope and change controls the organisation sets. Aevis makes no clinical, diagnostic or medical-device claim, and clinical safety assessment and system ownership remain with the accountable clinical and information governance roles.
By identifying them in the dependency map first, so that ordinary change practice is never applied to them by default. Where a change touches a qualified environment, its qualification impact is assessed as part of the change record rather than discovered afterwards. The validation decision itself remains the client’s.
They are treated as a documented, owned exposure with compensating controls and a review date, rather than as a permanent gap that nobody re-examines. Segmentation, monitoring and access restriction usually do more here than an upgrade programme that clinical operations cannot absorb.
Access is scoped to the agreed operational purpose, under the client’s data-protection terms and its own information-governance approvals. Aevis does not require access to identifiable clinical data to operate most of this estate, and where any access is necessary it is defined, minimised and recorded before it is granted.
Yes. Front-line access speed, a failing interface, a security-operations gap or one modernisation question can all be sensible entry points. We still map adjacent dependencies so the local fix does not create a hidden failure elsewhere.
No. No technology provider can guarantee either. Aevis supports the operations, engineering, evidence and improvement practices within the agreed scope; the organisation retains responsibility for clinical safety, regulatory interpretation, formal compliance and business risk decisions.
Healthcare and life sciences enquiry
Bring us one clinical or research service, one recurring operational problem or one modernisation priority. We will use the first conversation to establish the service boundary, constraints and the evidence already available.